Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Lee

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2004
Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30)S C Burgess, J R Young, B J G Baaten, et al.
Journal of Virology|May 3, 2001
Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDVM S Parcells, S F Lin, R L Dienglewicz, et al.
Current Gerontology and Geriatrics Research|March 29, 2017
Age-Friendliness and Life Satisfaction of Young-Old and Old-Old in Hong KongAlma M L Au, Stephen C Y Chan, H M Yip, et al.
RMD Open|May 14, 2016
Malignancy incidence in 5294 patients with juvenile arthritisOmid Zahedi Niaki, Ann E Clarke, Rosalind Ramsey-Goldman, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
Vaccines|September 28, 2024
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED StudyCarol A Hitchon, Dawn M E Bowdish, Gilles Boire, et al.
Perspectives on Psychological Science : a Journal of the Association for Psychological Science|July 15, 2022
Consensus Goals in the Field of Visual MetacognitionDobromir Rahnev, Tarryn Balsdon, Lucie Charles, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
The Journal of Rheumatology|April 15, 2024
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) StudyDawn M E Bowdish, Vinod Chandran, Carol A Hitchon, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2004
Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30)S C Burgess, J R Young, B J G Baaten, et al.
Journal of Virology|May 3, 2001
Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDVM S Parcells, S F Lin, R L Dienglewicz, et al.
Current Gerontology and Geriatrics Research|March 29, 2017
Age-Friendliness and Life Satisfaction of Young-Old and Old-Old in Hong KongAlma M L Au, Stephen C Y Chan, H M Yip, et al.
RMD Open|May 14, 2016
Malignancy incidence in 5294 patients with juvenile arthritisOmid Zahedi Niaki, Ann E Clarke, Rosalind Ramsey-Goldman, et al.
ACR Open Rheumatology|July 2, 2024
Duration of Postvaccination Neutralizing Antibodies to SARS-CoV-2 and Medication Effects: Results from the Safety and Immunogenicity of COVID-19 Vaccination in Systemic Immune-Mediated Inflammatory Diseases Cohort StudyRami Habib, Roya M Dayam, Carol Hitchon, et al.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
Vaccines|September 28, 2024
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED StudyCarol A Hitchon, Dawn M E Bowdish, Gilles Boire, et al.
Perspectives on Psychological Science : a Journal of the Association for Psychological Science|July 15, 2022
Consensus Goals in the Field of Visual MetacognitionDobromir Rahnev, Tarryn Balsdon, Lucie Charles, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
The Journal of Rheumatology|April 15, 2024
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) StudyDawn M E Bowdish, Vinod Chandran, Carol A Hitchon, et al.
Pageof 15